Introduction {#S1}
============

Ameloblastoma (Adamantinoma) is a benign odontogenic epithelial tumor.^1^ It accounts for 1% of all endodermal tumors and 11% of odontogenic tumors. It arises most frequently from the residue of dental ledge, enamel organ or Malassez epithelial rests or basal layer of oral epithelium.^[@R2]--[@R4]^ The exact aetiology is not known.^2^ The tumor frequently develops in the mandible (80%), maxilla (16%) while peripheral adamantinoma located in the soft tissue account for remaining 4%.^2^ In the mandible, it frequently involves molar & mandibular angle (70%), premolar (20%) and rarely anterior region (10%).^2^ It is a slow growing tumor, with equal gender prevalence. These are usually asymptomatic and presents with bony deformity.

Preoperative imaging including orthopantogram (OPG), computed tomography (CT scan), magnetic resonance imaging (MRI) and 3D CT scan play important role in planning extent of surgical resection. Treatment modalities include surgical excision, enucleation, curettage, cryotherapy, radiotherapy and chemotherapy. Wide surgical excision with safe margins is the preferred treatment method.

We present a rare case of anterior mandibular ameloblastoma (\<10%) arising from symphysis-menti, for which segmental resection of mandible was done with simultaneous reconstruction using free fibula vascular flap stabilized with reconstructive titanium plates.

Case Report {#S2}
===========

A 42-year-old male patient was admitted with lower jaw swelling of three years duration. Initially he was asymptomatic, however he then complained of bony deformity with gradual spontaneous fall of lower central teeth, difficulty in opening mouth and chewing food since 3--4 months.

On examination, patient had a huge bony tumor of the mandible with a *parchment crunch* feel. It was extending from left second premolar to the first premolar on right, predominantly affecting anterior segment of mandible. Overlying skin was freely mobile ([Figure 1](#F1){ref-type="fig"}a). Intraorally, tumor was extending into sublingual region displacing tongue with loss of lower incisor and canine teeth ([Figure 1](#F1){ref-type="fig"}b). There were few mucosal ulcerations. No cervical lymphadenopathy was noted.

Figure 1Preoperative external appearance of lower jaw swelling. (a) Frontal view. (b) Intraoral view showing tumor extending into sublingual region.

OPG displayed a multilocular, osteolytic defect predominantly around midline extending to left and right causing marked expansion in the lower part with thinning of cortex of the mandible. A 3D CT scan revealed the presence of an expansive, multilocular, lytic lesion centered on the symphysis-menti ([Figure 2](#F2){ref-type="fig"}a) and extending into parasymphyseal region and into the proximal body of the mandible on the left side ([Figures 2](#F2){ref-type="fig"}b and [2](#F2){ref-type="fig"}c). It was extending exophytically both anteriorly and inferiorly measuring 7.4×4.7×4.7 cm in size.

Figure 23D computed tomography revealing large expansile, multiseptate, lytic lesion involving (a) anterior portion of mandible. (b, c) tumor extension into left lateral part of the mandible.

Wide local excision of central part of mandible was performed with simultaneous reconstruction using free fibular vascular flap, stabilized with a titanium reconstructive plates ([Figure 3](#F3){ref-type="fig"}).

Figure 3Autogenous osseomyocutaneous fibular flap (arrow) shaped into mandibular contour with reconstructive titanium plates (arrow head).

Gross specimen showed few cystic areas with more solid component ([Figure 4](#F4){ref-type="fig"}a) and cut section revealed cystic areas with few areas of necrosis and hemorrhage ([Figure 4](#F4){ref-type="fig"}b).

Figure 4Specimen showing (a) tumor involving anterior and left lateral segment of the mandible and (b) cut section showing predominant solid component with few cystic areas.

Histology confirmed ameloblastoma with negative free margin ([Figure 5](#F5){ref-type="fig"}a). Immunohistochemistry report revealed ameloblastoma positive for cytokeratin 5 and 6 ([Figure 5](#F5){ref-type="fig"}b) and cytokeratin 14, negative for CD 68, cytokeratin 8 and 18 and calretinin.

Figure 5(a) Histology showing basal layer with stellate reticulum like epithelium. (b) Tumor cells positive for cytokeratin 5 and 6.

Postoperative course was uneventful. Follow up x-rays showed almost normal contour of lower jaw ([Figure 6](#F6){ref-type="fig"}a) and good cosmesis ([Figure 6](#F6){ref-type="fig"}b) with normal jaw movements and normal healing bone graft. Patient is on follow up for 1 year with and 3D CT scan showed no local recurrence ([Figures 6](#F6){ref-type="fig"}c and [6](#F6){ref-type="fig"}d). Patient is on follow up for prosthetic rehabilitation to restore missing tooth (dental implantation). Present case highlights the importance of functional reconstruction along with cosmesis in an adult male after wide excision of anterior mandible.

Figure 6Post-operative (a) X-ray revealing normal anatomical bone contour of the mandible supported by reconstructive plates and (b) anterior appearance of mandibular region on day 14 (good cosmesis). (c) Reconstructed Postoperative 3D CT scan (at 1 year follow up) revealing no local recurrence. Red arrows showing titanium reconstructive plates, (d) mandible with free fibular vascular flap.

Discussion {#S3}
==========

Ameloblastoma (from the early English word *amel*, meaning enamel and the greek word *blastos*, meaning germ) is a rare, benign odontogenic tumor of epithelial origin. It was described in 1827 by Cusack and designated as an Adamantinoma in 1885 by the French physician Louis-Charles Malassez and renamed as Ameloblastoma in 1930 by Ivey and Churchill.^[@R1]^ Unicystic ameloblastoma, a variant was first described by Robinson and Martinez.^[@R5]^

Ameloblastoma are usually diagnosed between the 4^th^ and 5^th^ decades of life except in unicystic variety (accounts for 6%), which is diagnosed between the ages of 20 and 30 years. No gender predominance is noted.^[@R6]^ About 10--15% of the tumors are often linked to a nonerupted tooth (impacted wisdom tooth).^[@R7]^ Ameloblastoma are usually asymptomatic and found on routine dental x-rays; however they present with jaw expansion. Its slow but relentless growth may cause movement of tooth roots or root resorption. In our case patient had lower jaw swelling with bony deformity and gradual spontaneous fall of lower central incisor and canine teeth, difficulty in opening mouth and chewing food.

Radiographically, it can either be unicystic intraosseous, multicystic, solid intraosseous (80--90%) or peripheral.^[@R8]^ These are histologically classified into follicular, granular, lexiform, desmoplastic, basal cell and acanthomatous variety.^[@R9]^ Diagnosis is usually made by fine needle aspiration, which reveals *palisaded basal cell layer with stellate reticulum like epithelium*. Immunohistochemistry study revealed tumor cells positive for keratin and express CK 5, 6 and 14, few cells also reactive for cytokeratin 8, 18 and 19. Calretinin is expressed by certain solid and multicystic ameloblastoma. Granular cell ameloblastoma specifically express CD 56 and S-100 protein along with keratins. In the present case, ameloblastoma was of follicular variety and on immunohistochemistry study tumor cells, positive for cytokeratins 5 and 6 and cytokeratin 14, negative for CD 68, cytokeratin 8 and 18 and calretinin.

According to World Health Organization histological typing of odontogenic tumor, second edition 1992, ameloblastoma are further sub-classified as summarized in [Table 1](#T1){ref-type="table"}.^[@R10]^

Table 1Ameloblastoma subclassification, according to World Health Organization (1992).BenignOdontogenic epithelium without odontogenic ectomesenchymeOdontogenic epithelium with odontogenic ectomesenchyme with or without dental hard tissue formationAmeloblastoma;Squamous odontogenic tumor;Clear cell odontogenic tumor;Calcified epithelial odontogenic tumor.Complex/ compound odontoma;Calcified odontogenic cyst.Ameloblastoma fibroma;Ameloblastoma fibrodentinoma and fibro-odontoma;Odontoameloblastoma;Adenomatoid odontogenic tumor;MalignantOdontogenic sarcomaOdontogenic fibrosarcomaOdontogenic carcinosarcomaMalignant ameloblastoma;Primary intraosseous carcinoma;Malignant change in odontogenic cyst.Ameloblastic fibrosarcoma;Ameloblastic fibrodentinosarcoma and fibroodontosarcoma.

Ameloblastoma rarely shows malignant change, accounting for less than 1% of cases. Malignant ameloblastoma may arise *de novo* or transformation of pre-existing ameloblastoma. These usually occur in adults, aggressive in nature with poor outcome. Most common site of spread includes lung, cervical lymph nodes and rarely brain.

Surgery is the mainstay of treatment and involves complete removal of tumor with negative margin of 15--20 mm.^[@R2]^ Segmental resection, hemi resection or complete enucleation of mandible with simultaneous and final reconstruction of the postoperative defect gives normal contour and better functional ability which is only possible when the patient's general condition is good. A free vascularized fibula flap offers the best option for mandibular reconstruction and subsequent dental implantation. The autogenic bone transplant from the iliac ala, fibula, scapula or radius is currently believed to be one of the best methods for mandible reconstruction. In most cases described in literature the results are satisfactory both in terms of functionality and aesthetics. There is little information available in the literature regarding the role of radiotherapy, as a useful modality of treatment in case ameloblastoma.^[@R11]^ Role of chemotherapy is not yet well defined, either single agent or combination chemotherapy have been used for palliation in patients with irresectable metastasis but only few reports showed little response (Cisplatin and Paclitaxel).^[@R12]^ Among surgical modalities, recurrence rates were 3.6% for wide resection, 30.5% for enucleation and 16% for enucleation followed by use of Carnoy's solution. Few reports are available in the literature regarding recurrence of ameloblastoma in the grafted bone. Hence long-term follow up is recommended for more than 10 years at regular intervals after appropriate surgical operation. Patient should be on clinical and radiological follow up irrespective of the treatment done.
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